We are dedicated to identifying and advancing innovative solutions to some of our nation’s most pressing challenges.

“Overdose deaths related to illicit substances, such as fentanyl and cocaine, have continued to climb in spite of the government’s supply-reduction efforts.”

Demanding Better: A Case for Increased Funding and Involvement of State Medical Boards in Response to America’s Drug Abuse Crisis

Trending Research

“When developing strategies to prevent opioid or other substance misuse, stakeholders should bear in mind that individuals often do not use a singular substance.”

Polysubstance Use Among People Who Use Opioids or Other Drugs Nonmedically
A Literature Review

 

 

Featured Initiatives

Media

CUSP Names Executives ‘Qualified and Ready on Day One’

December 15, 2020

Nonprofit tells Biden-Harris Transition Team that no woman has ever served as drug czar and states, “It is time for a woman to hold that position.”

DEA Expanding Surveillance of Prescription Drug Data

November 11, 2020

CUSP’s chairman discusses the impact of the new RFP from the DEA that asks software contractors to create a nationwide data system that will increase the surveillance of prescriptions.

Feds Warn of Scammers Impersonating DEA Agents

August 5, 2020
The U.S. Drug Enforcement Agency (DEA) warns doctors, pharmacists, and the public about criminals posing as DEA agents and attempting to extort money from them. CUSP’s chairman cautions that the scammers have enough knowledge of the tactics DEA is employing against controlled-medication prescribers to be able to replicate them in other situations.

“Not all health care professionals subject to the DOJ’s searches and seizures are ‘dirty docs.’ In fact, some of them are nationally recognized leaders not just in pain management, but also in addiction medicine”

A More Sensible Surge: Ending DOJ's Indiscriminate Raids of Healthcare Providers
Legislation & Policy Brief

Collaborating Organizations

Engage

Center for U.S. Policy

info@c4usp.org

Newsletter Sign-up

Oklahoma Att'y Gen @agmikehunter & NC Att'y Gen @JoshStein_ present strong arguments that Congress cannot wait any longer to #XtheXwaiver. We agree. https://thehill.com/opinion/healthcare/540186-x-the-x-waiver-how-congress-can-facilitate-treatment-for-opioid-abuse

A strong statement on #RacialJustice from @ASAMorg. We agree with their analyses and recommendations. Well done @DrAGB, et al. https://www.asam.org/advocacy/find-a-policy-statement/view-policy-statement/public-policy-statements/2021/02/26/public-policy-statement-on-advancing-racial-justice-in-addiction-medicine

We are pleased to see @ReginaLabelle, Pres. Biden's current acting director of #ONDCP, will stay on as deputy director. Strong signal of progress to come on access to SUD treatment (incl for incarcerated ppl), OTC #naloxone, and justice reforms.
https://filtermag.org/ondcp-biden-priorities/

This common-sense bill by @SenBillCassidy, @SenatorBaldwin, & @SenatorShaheen would limit #corporatewelfare, promote #competition, and reduce #drugprices. Thank you, Senators, for your #bipartisan leadership.
https://www.cassidy.senate.gov/newsroom/press-releases/cassidy-baldwin-shaheen-introduce-bill-to-close-orphan-drug-loophole

Load More...